The Centers for Medicare & Medicaid Services’ proposed rule on the standards governing health insurance issuers and the Health Insurance Marketplaces for 2021 includes a number of policies that could benefit patients by lowering drug prices and premiums, incentivizing use of high-value services and ensuring premium dollars are spent wisely, AHA said in comments submitted yesterday.

“We are concerned, however, that CMS continues to consider changes to automatic reenrollment, which could result in the loss of coverage for vulnerable enrollees and contribute to marketplace destabilization,” AHA said. “We are also concerned about the continued rise in annual cost-sharing limits, which many Americans already struggle to afford.”

AHA encouraged the agency to “go further in future rulemaking to advance policies that will not only maintain the status quo but also build on the progress already made. Such policies include substantially increasing funding for outreach and enrollment efforts, extending the open enrollment period, and increasing lower- and middle-income individuals and families’ access to premium tax credits.”
 

Related News Articles

Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
An analysis by KFF released Jan. 28 found that Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023. The finding…
Headline
The AHA Jan. 28 voiced support for bipartisan legislation to reauthorize for five years the Dr. Lorna Breen Health Care Provider Protection Act, which provides…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The AHA Jan. 27 voiced support for the Centers for Medicare & Medicaid Services proposed rule on policy and technical changes to Medicare Advantage and…
Headline
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that…